Compound ID | 1911
Synonym(s): SM-1652
Class: Beta-lactam (cephalosporin, third generation)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and against many Enterobacteriaceae but vulnerable to extended-spectum beta-lactamases (ESBL) |
Description: | Semisynthetic Cephalosporine, derived from Cephalosporin C |
Institute where first reported: | Wyeth Ayerst |
Year first mentioned: | 1982 |
Highest developmental phase: | Approved by FDA in 1989 |
Development status: | Discontinued |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/636405 |
Guide to Pharmacology: | cefpiramide |
Citation: | https://www.jiac-j.com/article/S1341-321X(00)71317-1/fulltext |